홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ANAB
#1840
AnaptysBio, Inc. Common Stock
55.050
0
+1.79%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+1.79%
월간 변동
+11.53%
6달 변화
+56.39%
년간 변동율
+56.39%
이전 종가
54.080
0
Open
55.050
0
Bid
Ask
Low
55.050
0
High
55.146
0
양
74
마켓
주식
헬스케어
ANAB
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
30.43 M
30.67 M
29.38 M
28 M
27.69 M
—
Valuation ratios
Enterprise value
827.78 M
282.95 M
447.55 M
577.23 M
737.99 M
2.05 B
Price to earnings ratio
-5.51
-2.59
-3.91
-5.06
-11.22
-22.76
Price to sales ratio
16.02
4.12
4.75
5.21
5.28
19.36
Price to cash flow ratio
-8.78
-2.78
-4.83
-5.03
-6.13
-18.76
Price to book ratio
3.96
5.3
2.65
4.31
28.07
40.34
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.07
0.05
0.09
0.12
0.04
0.3
Return on equity %
0.39
0.31
1.16
0.86
0.51
2.84
Return on invested capital %
167.79
76.13
190.36
197.25
244.78
708.52
Gross margin %
100
100
100
100
100
400
Operating margin %
75.81
22.43
99.16
117.55
45.47
284.62
EBITDA margin %
—
—
—
—
—
—
Net margin %
109.44
50.53
141.62
173.52
19.8
385.47
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.23
9.51
8.25
8.22
8.68
34.65
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.07
0.09
0.06
0.06
0.22
0.43
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.35
2.35
0.35
1.4
0.94
5.04
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
14.89
13.58
11.09
9.22
8.58
42.47
Net current asset value per share
15.53
15.22
11.85
10.13
11.39
48.59
Tangible book value per share
2.92
2.5
1.11
1.55
1.01
6.17
Working capital per share
14.01
13.62
10.41
8.9
10.08
43.01
Book value per share
2.92
2.5
1.11
1.55
1.01
6.17
뉴스
반다, 희귀 피부 질환 치료제 ’임시돌리맙’ FDA 승인 신청 접수
FDA accepts Vanda’s imsidolimab application for rare skin disorder
AnaptysBio, 52주 신고가 경신, 주당 57.73달러
AnaptysBio stock hits 52-week high at $57.73
These IBD 50 Stocks Form Secondary Buy Areas, But Watch These Risks
AnaptysBio, 52주 신고가 기록, $52.56
AnaptysBio stock hits 52-week high at $52.56
Biotech Leader Eyes Spinoff Amid Massive Sales Surge
AnaptysBio, Inc. (ANAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
AnaptysBio: UBS, GSK 소송 중 ’매수’ 등급 유지
AnaptysBio stock: UBS reiterates Buy rating amid ongoing GSK litigation
로열티 파마-Teva의 5억 달러 IL-15 계약에 AnaptysBio 주가 상승